Dietary starch may raise risk of breast cancer recurrence

Share this article:

An increase in carbohydrate intake—particularly starch intake—has been linked with breast cancer recurrence in a study presented at the CTRC-AACR San Antonio Breast Cancer Symposium, held December 6-10, 2011, in San Antonio, Texas.

Jennifer A. Emond, MS, a public health doctoral student at the University of California, San Diego, and colleagues conducted a subset analysis of 2,651 women who participated in the Women's Healthy Eating and Living (WHEL) Dietary Intervention Trial for survivors of breast cancer—a plant-based intervention trial that did not have a carbohydrate goal. Participants were followed for an average of 7 years.

The investigators obtained information on patients' carbohydrate consumption from multiple 24-hour dietary recalls at baseline and at 1 year, and from annual phone interviews in which the women reported everything they had eaten in the preceding 24 hours.

Baseline carbohydrate intake was 233 g/day. Women who experienced a breast cancer recurrence had a mean increase in carbohydrate intake of 2.3 g/day over the first year. By comparison, those who did not have a recurrence had a mean decrease in carbohydrate intake of 2.7 g/day). Change in starch intakes accounted for nearly half (48%) of the change in carbohydrate intake: Mean first-year change in starch intake, which was achieved independent of the study intervention, was –4.1 g/day among women with recurrences and –8.7 g/day among the others.

When starch intake changes during 1 year were grouped into quartiles of change, women who increased their starch intake the most during that period had a recurrence rate of 14.2%, compared with 9.7% among the women who reduced their starch intake the most. In an adjusted model, an increase in starch of 5 g/day related to a 3% increased risk of recurrence. The increased risk was limited to women diagnosed with low-grade tumors.

The results suggest that dietary modifications targeting starch intake should be investigated further as a preventive measure against breast cancer recurrence.

Share this article:
You must be a registered member of ONA to post a comment.

Next Article in Web Exclusives

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Hope for preserving fertility in young boys with cancer

Scientists have moved a step closer to being able to preserve fertility in young boys who undergo chemotherapy and radiation treatments for cancer.

Certain genetic variants increase recurrence risk for bladder cancer

Inheriting certain DNA sequences can affect the prognosis of bladder cancer patients, according to a new study.

Adult cancer drug offers hope against aggressive pediatric brain tumor

The quest to improve survival of children with a high-risk brain tumor has led investigators to two drugs already used to treat adults with breast, pancreatic, lung, and other cancers.